Plexus (NASDAQ:PLXS) Releases Q1 2025 Earnings Guidance

Plexus (NASDAQ:PLXSGet Free Report) updated its first quarter 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 1.520-1.670 for the period, compared to the consensus estimate of 1.540. The company issued revenue guidance of $960.0 million-$1.0 billion, compared to the consensus revenue estimate of $1.0 billion. Plexus also updated its Q1 guidance to $1.52-$1.67 EPS.

Plexus Stock Performance

PLXS stock traded up $9.32 during midday trading on Thursday, hitting $144.89. The company’s stock had a trading volume of 493,564 shares, compared to its average volume of 127,949. The stock has a market cap of $3.95 billion, a price-to-earnings ratio of 36.50 and a beta of 0.89. The company has a quick ratio of 0.64, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The stock’s 50-day moving average price is $130.05 and its 200 day moving average price is $115.62. Plexus has a 1 year low of $87.21 and a 1 year high of $153.60.

Plexus (NASDAQ:PLXSGet Free Report) last issued its quarterly earnings results on Wednesday, October 23rd. The technology company reported $1.85 earnings per share for the quarter, topping analysts’ consensus estimates of $1.55 by $0.30. The company had revenue of $1.05 billion for the quarter, compared to the consensus estimate of $1.01 billion. Plexus had a net margin of 2.82% and a return on equity of 9.64%. The firm’s quarterly revenue was up 2.6% on a year-over-year basis. During the same period in the previous year, the firm earned $1.44 EPS. On average, equities analysts forecast that Plexus will post 3.74 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. KeyCorp started coverage on shares of Plexus in a research note on Tuesday. They set a “sector weight” rating for the company. Needham & Company LLC raised their target price on Plexus from $114.00 to $144.00 and gave the stock a “buy” rating in a research report on Friday, July 26th. Finally, Benchmark restated a “buy” rating and issued a $150.00 target price on shares of Plexus in a research note on Monday. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, Plexus presently has a consensus rating of “Hold” and a consensus target price of $125.25.

View Our Latest Stock Report on PLXS

Insiders Place Their Bets

In other news, Director Karen Marie Rapp sold 500 shares of Plexus stock in a transaction on Friday, August 30th. The stock was sold at an average price of $128.02, for a total value of $64,010.00. Following the completion of the transaction, the director now directly owns 9,586 shares in the company, valued at approximately $1,227,199.72. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, insider Steven J. Frisch sold 6,565 shares of the company’s stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $128.11, for a total transaction of $841,042.15. Following the sale, the insider now owns 36,118 shares of the company’s stock, valued at approximately $4,627,076.98. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Karen Marie Rapp sold 500 shares of the stock in a transaction on Friday, August 30th. The stock was sold at an average price of $128.02, for a total value of $64,010.00. Following the completion of the sale, the director now owns 9,586 shares in the company, valued at $1,227,199.72. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 20,113 shares of company stock worth $2,541,394 over the last 90 days. Corporate insiders own 2.39% of the company’s stock.

About Plexus

(Get Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Further Reading

Earnings History and Estimates for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.